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Kaposi sarcoma-associated herpesvirus (KSHV) encodes
12 pre-microRNAs which potentially yield 25 mature
microRNAs and have been shown to play prominent
roles in the viral lifecycle including maintaining viral
latency, evading the host immune response, and control-
ling lytic replication. We previously reported phyloge-
netic analysis of the microRNA-coding region of KSHV
from Kaposi sarcoma (KS), primary effusion lymphoma
(PEL), and multicentric Castleman disease (MCD)
patients. We showed a high level of conservation for
most sequences, but also a divergent cluster of 5 KSHV
sequences including 2 from MCD patients [1]. We addi-
tionally observed single nucleotide polymorphisms
(SNP) in the sequence of KSHV encoded mature and
pre-miRNAs from clinical samples including a SNP in
mir-K12-5 reported to result in increased expression of
the mature miRNA [2].
To determine whether SNPs in other KSHV encoded
miRNAs resulted in differences in miRNA processing and
expression we used four complimentary approaches.
Analysis of KSHV miRNA expression levels in PEL cell
lines using custom ABI real time qPCR assays showed
differential expression that correlates with sequence.
Lentiviral vectors constructed to express wild type and
variant pre-miRNAs were transduced into 293T cells to
make stably expressing cell lines. miRNA expression was
assessed using custom ABI real time qPCR assays. Lucifer-
ase reporter assays were performed following transient
transfections of each miRNA. In addition, in vitro matura-
tion assays were performed to assess differences in
Drosha/DGCR8 and Dicer cleavage between wild type and
variant pre-miRNAs. Our results indicate that polymorph-
isms within the pre-miRNA sequence can cause subtle
expression differences as in the case of KSHV miR-K12-6
or more profound changes as observed in miR-K12-5. Our
data clearly shows that SNPs can affect pre-miRNA pro-
cessing resulting in changes in mature miRNA expression
levels.
To extend our studies on miRNA variation in MCD
patients, KSHV miRNA sequences from 23 MCD
patients and 7 patients with a newly described KSHV-
associated inflammatory cytokine syndrome (KICS) were
examined by amplification, cloning, and sequencing of a
646-bp fragment of K12/T0.7 encoding miRNA-K12-10
and miRNA-K12-12 and a 2.8-kbp fragment containing
the remaining 10 pre-microRNAs. Phylogenetic analysis
showed a distinct variant cluster consisting exclusively
of MCD and KICS patients in all trees. Pearson’sc h i -
squared analysis revealed 40 single nucleotide poly-
m o r p h i s m s( S N P s )a tv a r i o u sl o c iw e r es i g n i f i c a n t l y
associated with MCD and KICS risk. Additionally, clus-
ter analysis of these SNPs generated several combina-
tions of three SNPs as putative indicators of MCD and
KICS risk. Taken together, these findings show that
MCD and KICS patients frequently have unusual KSHV
microRNA sequences and suggest association between
the observed sequence variation and risk of MCD and
KICS. * Correspondence: denise.whitby@nih.gov
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